In Vivo Activity of the Pyrrolopyrazolyl-Substituted Oxazolidinone RWJ-416457

gan Hilliard, Jamese J., Fernandez, Jeffrey, Melton, John, Macielag, Mark J., Goldschmidt, Raul, Bush, Karen, Abbanat, Darren
Cyhoeddwyd 2009

In Vitro Antibacterial Activities of JNJ-Q2, a New Broad-Spectrum Fluoroquinolone

gan Morrow, Brian J., He, Wenping, Amsler, Karen M., Foleno, Barbara D., Macielag, Mark J., Lynch, A. Simon, Bush, Karen
Cyhoeddwyd 2010

Discovery of a Novel Series of Pyridone-Based EP3 Antagonists for the Treatment of Type 2 Diabetes

gan Zhang, Xuqing, Zhu, Bin, Guo, Lili, Bakaj, Ivona, Rankin, Matthew, Ho, George, Kauffman, Jack, Lee, Seunghun P., Norquay, Lisa, Macielag, Mark J.
Cyhoeddwyd yn ACS Med Chem Lett (2021)

In Vitro Antibacterial Activity of the Pyrrolopyrazolyl-Substituted Oxazolidinone RWJ-416457

gan Foleno, Barbara D., Abbanat, Darren, Goldschmidt, Raul M., Flamm, Robert K., Paget, Steve D., Webb, Glenda C., Wira, Ellyn, Macielag, Mark J., Bush, Karen
Cyhoeddwyd 2007

Crystal structure of a soluble form of human monoglyceride lipase in complex with an inhibitor at 1.35 Å resolution

gan Schalk-Hihi, Céline, Schubert, Carsten, Alexander, Richard, Bayoumy, Shariff, Clemente, Jose C, Deckman, Ingrid, DesJarlais, Renee L, Dzordzorme, Keli C, Flores, Christopher M, Grasberger, Bruce, Kranz, James K, Lewandowski, Frank, Liu, Li, Ma, Hongchang, Maguire, Diane, Macielag, Mark J, McDonnell, Mark E, Mezzasalma Haarlander, Tara, Miller, Robyn, Milligan, Cindy, Reynolds, Charles, Kuo, Lawrence C
Cyhoeddwyd 2011